Close X
Friday, November 22, 2024
ADVT 
International

WHO: Rich countries should donate vaccines, not use boosters

Darpan News Desk The Canadian Press, 12 Jul, 2021 11:20 AM
  • WHO: Rich countries should donate vaccines, not use boosters

Top officials at the World Health Organization say there's not enough evidence to show that third doses of coronavirus vaccines are needed and appealed Monday for the scarce shots to be shared with poor countries who have yet to immunize their people instead of being used by rich countries as boosters.

At a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said the world's grotesque vaccine disparity was driven by “greed,” as he called on drugmakers to prioritize supplying their COVID-19 vaccines to poor countries instead of lobbying rich countries to use even more doses. His plea comes just as pharmaceutical companies are seeking authorization for third doses to be used as boosters in some Western countries, including the U.S.

“We are making conscious choices right now not to protect those in need,” Tedros said, adding the immediate priority must be to vaccinate people who have yet to receive a single dose.

He called on Pfizer and Moderna to “go all out to supply COVAX, the Africa Vaccine Acquisition Task Team and low and middle-income countries with very little coverage,” referring to the U.N.-backed initiative to distribute vaccines globally.

After a 10-week drop in global coronavirus deaths, Tedros said the number of COVID-19 patients dying daily is again beginning to climb and that the extremely infectious delta variant is “driving catastrophic waves of cases.”

Both Pfizer and Moderna have agreed to supply small amounts of their vaccines to COVAX, but the vast majority of their doses have been reserved by rich countries. The U.N.-backed effort has faltered badly in recent months, with nearly 60 poor countries stalled in their vaccination efforts and their biggest vaccine supplier unable to share any doses until the end of the year.

Pfizer is meeting with top U.S. officials on Monday to discuss its request for federal authorization for a third booster dose. Last week, the company said a third dose could dramatically boost immunity and perhaps help ward off worrisome variants.

Britain is also considering a possible booster vaccination plan in the fall, which would likely target those over 50 and the most vulnerable.

But WHO’s top experts disputed the need for a booster in fully immunized people.

“At this point...there is no scientific evidence to suggest that boosters are definitely needed,” said Dr. Soumya Swaminathan, WHO’s chief scientist. Swaminathan said WHO would make recommendations on booster doses if they were needed, but that any such advice “has to be based on the science and data, not on individual companies declaring that the vaccines should now be administered as a booster dose."

Dr. Michael Ryan, WHO's emergencies chief, suggested that if rich countries decide to administer booster shots rather than donating them to the developing world, “we will look back in anger and I think we will look back in shame.”

He said the failure to increase vaccine manufacturing capacity, coupled with rich countries' refusal to share shots with poor countries, was extremely disappointing.

“This is people who want to have their cake and eat it," he said. "Then they make some more cake and they want to eat that as well.”

Some experts called the idea of booster shots “morally repugnant,” given the explosive spread of COVID-19 now being seen in some African countries.

Tom Hart, acting CEO of the ONE campaign, an advocacy group, noted that just 1% of people in poor countries have received even one COVID-19 vaccine dose.

"The idea that a healthy, vaccinated person can get a booster shot before a nurse or grandmother in South Africa can get a single jab is outrageous,” he said.

MORE International ARTICLES

How long does protection from COVID-19 vaccines last?

How long does protection from COVID-19 vaccines last?
So far, Pfizer's ongoing trial indicates the company's two-dose vaccine remains highly effective for at least six months, and likely longer. People who got Moderna’s vaccine also still had notable levels of virus-fighting antibodies six months after the second required shot.

How long does protection from COVID-19 vaccines last?

Biden hints at more vaccine help for Canada

Biden hints at more vaccine help for Canada
The U.S. has already provided Canada with about 1.5 million doses of the AstraZeneca vaccine, and gave 2.5 million doses to Mexico.

Biden hints at more vaccine help for Canada

DOJ to investigate police practices in Minneapolis

DOJ to investigate police practices in Minneapolis
Attorney General Merrick Garland says the investigation will look into the department's use of force and whether it engaged in discriminatory practices.

DOJ to investigate police practices in Minneapolis

UPDATE: The names of the victims killed in the Indianapolis shooting released, half of them Sikhs

UPDATE: The names of the victims killed in the Indianapolis shooting released, half of them Sikhs
Police did not release the names of those who were injured and taken to hospital. The Sikh Coalition and the Sikh Community reeling from the loss of their loved ones and sharing their grief condemning this senseless act of violence over social media posts. 

UPDATE: The names of the victims killed in the Indianapolis shooting released, half of them Sikhs

Majority of employees killed and wounded in shooting at a FedEx facility in Indianapolis from the Sikh Community

Majority of employees killed and wounded in shooting at a FedEx facility in Indianapolis from the Sikh Community
According to Indiana police the motive of the gunman on opening fire Thursday night at a FedEx processing centre near the Indianapolis airport is not known. The shooter started randomly firing at people in the parking lot and then went into the building and continued shooting. 

Majority of employees killed and wounded in shooting at a FedEx facility in Indianapolis from the Sikh Community

US recommends 'pause' for J&J vaccine

US recommends 'pause' for J&J vaccine
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.

US recommends 'pause' for J&J vaccine